Pharmaceuticals - Cambodia

Cambodia

The Pharmaceuticals market in Cambodia is expected to generate a revenue of US$177.00m in 2024.
Among the various markets, Oncology Drugs is projected to hold the largest market share with a volume of US$30.00m in the same year.
It is anticipated that the revenue will witness a steady annual growth rate of 5.47% (CAGR 2024-2028), leading to a market volume of US$219.00m by 2028.
When compared globally, United States is forecasted to generate the highest revenue, amounting to US$636.90bn in 2024.
Cambodia's pharmaceutical market is growing rapidly, driven by increasing healthcare investments and a rising demand for affordable and accessible healthcare solutions.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Cambodia has been growing steadily in recent years, driven by various factors.

Customer preferences: Cambodian customers tend to prefer traditional medicine and home remedies over modern pharmaceuticals. However, there has been a shift towards modern medicine due to increasing awareness and education about the benefits of Western medicine. Additionally, the growing middle class in Cambodia has led to an increase in demand for higher quality healthcare products.

Trends in the market: One major trend in the Cambodian Pharmaceuticals market is the increasing demand for generic drugs. This is due to the lower cost of generic drugs compared to branded drugs, which makes them more accessible to the general population. Another trend is the growth of the over-the-counter (OTC) market, which includes products such as vitamins, supplements, and pain relievers. This is driven by the increasing awareness of the importance of preventive healthcare and self-medication.

Local special circumstances: Cambodia has a relatively small pharmaceutical industry, with most drugs being imported from other countries. This has led to concerns about the quality and safety of drugs, as well as the lack of regulation in the market. However, the government has been taking steps to address these issues, such as implementing stricter regulations and increasing inspections of pharmaceutical products.

Underlying macroeconomic factors: The Cambodian economy has been growing steadily in recent years, with a focus on developing the healthcare sector. This has led to increased investment in healthcare infrastructure and services, which has in turn driven growth in the pharmaceuticals market. Additionally, the government has been promoting the development of local pharmaceutical manufacturing, which has the potential to further boost the market. However, challenges such as limited access to financing and a lack of skilled labor in the industry remain.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.